Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Arcutis Biotherapeutics (ARQT) EPS (Basic) (2021 - 2025)

Historic EPS (Basic) for Arcutis Biotherapeutics (ARQT) over the last 5 years, with Q3 2025 value amounting to $0.06.

  • Arcutis Biotherapeutics' EPS (Basic) rose 11818.18% to $0.06 in Q3 2025 from the same period last year, while for Sep 2025 it was -$0.35, marking a year-over-year increase of 7891.57%. This contributed to the annual value of -$1.16 for FY2024, which is 6937.16% up from last year.
  • Arcutis Biotherapeutics' EPS (Basic) amounted to $0.06 in Q3 2025, which was up 11818.18% from -$0.13 recorded in Q2 2025.
  • Over the past 5 years, Arcutis Biotherapeutics' EPS (Basic) peaked at $0.06 during Q3 2025, and registered a low of -$1.89 during Q3 2022.
  • Over the past 5 years, Arcutis Biotherapeutics' median EPS (Basic) value was -$0.76 (recorded in 2021), while the average stood at -$0.79.
  • Per our database at Business Quant, Arcutis Biotherapeutics' EPS (Basic) plummeted by 6710.53% in 2022 and then skyrocketed by 11818.18% in 2025.
  • Arcutis Biotherapeutics' EPS (Basic) (Quarter) stood at -$1.43 in 2021, then rose by 20.28% to -$1.14 in 2022, then soared by 48.25% to -$0.59 in 2023, then surged by 84.88% to -$0.09 in 2024, then soared by 167.27% to $0.06 in 2025.
  • Its EPS (Basic) was $0.06 in Q3 2025, compared to -$0.13 in Q2 2025 and -$0.2 in Q1 2025.